MSX-130

CAS No. 4051-59-6

MSX-130( MSX-130 | MSX 130 | MSX130 )

Catalog No. M17502 CAS No. 4051-59-6

MSX-130 is CXCR4 Antagonist.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 33 In Stock
5MG 51 In Stock
10MG 87 In Stock
25MG 188 In Stock
50MG 305 In Stock
100MG 477 In Stock
200MG 677 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    MSX-130
  • Note
    Research use only, not for human use.
  • Brief Description
    MSX-130 is CXCR4 Antagonist.
  • Description
    MSX-130 is CXCR4 Antagonist.
  • In Vitro
    The C-X-C chemokine receptor-4 (CXCR4) is a seven trans-membrane G-protein coupled receptor (GPCR) classified as a member of the family I GPCR or rhodopsin-like GPCR family. CXCR4 plays an important role in cancer metastasis, regulation of stem cell trafficking, and neovascularization.
  • In Vivo
    ——
  • Synonyms
    MSX-130 | MSX 130 | MSX130
  • Pathway
    Autophagy
  • Target
    CXCR
  • Recptor
    CXCR4
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4051-59-6
  • Formula Weight
    514
  • Molecular Formula
    C36H26N4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 2 mg/mL (3.89 mM)
  • SMILES
    c1(ccc(cc1)c1nc(c([nH]1)c1ccccc1)c1ccccc1)c1[nH]c(c(n1)c1ccccc1)c1ccccc1
  • Chemical Name
    2,2'-(1,4-Phenylene)bis[4,5-diphenyl-1H-imidazole]

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Weiqiang Zhan, et al. Discovery of Small Molecule CXCR4 Antagonists. J. Med. Chem., 2007, 50 (23), pp 5655–5664.
molnova catalog
related products
  • ALX 40-4C

    ALX40-4C is a small peptide inhibitor of the chemokine receptor CXCR4 that can inhibit X4 strains of HIV-1.

  • CHIR98014

    CHIR 98014 is a potent GSK-3α/β inhibitor with IC50 of 0.65 nM/0.58 nM in cell-free assays, with the ability to distinguish GSK-3 from its closest homologs Cdc2 and ERK2.

  • Ulocuplumab

    Ulocuplumab (BMS-936564) is a fully human anti-CXCR4 IgG4 antibody.Ulocplumab exhibits antitumor activity in acute myeloid leukemia (AML), non-Hodgkin's lymphoma (NHL), and multiple myeloma transplantation models.